Cargando…
Influence of substrate modification in catheter ablation of atrial fibrillation on the incidence of acute complications: Analysis of 10 795 procedures in J‐CARAF Study 2011‐2016
BACKGROUND AND PURPOSE: In expectation of better outcome of catheter ablation of atrial fibrillation (AF), several strategies of extra‐PV (pulmonary vein) substrate modification have been utilized. We assessed whether substrate modification or ablation of extra‐PV source is a predictor of complicati...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111468/ https://www.ncbi.nlm.nih.gov/pubmed/30167015 http://dx.doi.org/10.1002/joa3.12081 |
_version_ | 1783350663073234944 |
---|---|
author | Murakawa, Yuji Yamane, Teiichi Goya, Masahiko Inoue, Koichi Naito, Shigeto Kumagai, Koichiro Miyauchi, Yasushi Morita, Norishige Nogami, Akihiko Shoda, Morio Okumura, Ken Hirao, Kenzo |
author_facet | Murakawa, Yuji Yamane, Teiichi Goya, Masahiko Inoue, Koichi Naito, Shigeto Kumagai, Koichiro Miyauchi, Yasushi Morita, Norishige Nogami, Akihiko Shoda, Morio Okumura, Ken Hirao, Kenzo |
author_sort | Murakawa, Yuji |
collection | PubMed |
description | BACKGROUND AND PURPOSE: In expectation of better outcome of catheter ablation of atrial fibrillation (AF), several strategies of extra‐PV (pulmonary vein) substrate modification have been utilized. We assessed whether substrate modification or ablation of extra‐PV source is a predictor of complications. METHODS: Japanese Heart Rhythm Society requested electrophysiology centers to register the data of patients who underwent AF ablation. RESULTS: The data of 10 795 AF ablation cases (age; 63.8 ± 10.6 years) treated during 2011‐2016 were registered. Pericardial effusion (n = 105), massive bleeding (n = 108), stroke (n = 6), atrial‐esophageal fistula (n = 2), and other 114 complications occurred in 323 patients (3.0%). Univariate analysis revealed that age ≧ 65 years, female gender, heart failure, CHA2DS2‐VASc≧3, hemodialysis, deep sedation, and complex fractionated atrial electrogram (CFAE)‐guided ablation ([+] vs [−] = 4.3% vs 2.8%, P = .005) were related with the higher incidence of complications. Redo session, 3‐D imaging system ([+] vs [−]: 4.4% vs 2.9%, P = .017), and periprocedural dabigatran were related with the lower incidence of complications. None of the linear ablation of the left atrium, ganglionated plexi ablation, and superior vena cava ablation affected the incidence of complications. Multiple logistic regression analysis showed that in addition to 3‐D imaging system, age ≧ 65 years, redo session, and deep sedation, CFAE ablation was an independent predictor of the risk of complications (OR 1.78, P = .001). Specifically, implantation of a permanent pacemaker due to emerging sinus node dysfunction was frequent after CFAE ablation (CFAE [+] vs [−] = 4/1047 vs 2/9748, P < .001). CONCLUSIONS: Among extra‐PV ablation strategies, CFAE‐guided ablation is a predictor of ablation‐related complications. |
format | Online Article Text |
id | pubmed-6111468 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-61114682018-08-30 Influence of substrate modification in catheter ablation of atrial fibrillation on the incidence of acute complications: Analysis of 10 795 procedures in J‐CARAF Study 2011‐2016 Murakawa, Yuji Yamane, Teiichi Goya, Masahiko Inoue, Koichi Naito, Shigeto Kumagai, Koichiro Miyauchi, Yasushi Morita, Norishige Nogami, Akihiko Shoda, Morio Okumura, Ken Hirao, Kenzo J Arrhythm Original Articles BACKGROUND AND PURPOSE: In expectation of better outcome of catheter ablation of atrial fibrillation (AF), several strategies of extra‐PV (pulmonary vein) substrate modification have been utilized. We assessed whether substrate modification or ablation of extra‐PV source is a predictor of complications. METHODS: Japanese Heart Rhythm Society requested electrophysiology centers to register the data of patients who underwent AF ablation. RESULTS: The data of 10 795 AF ablation cases (age; 63.8 ± 10.6 years) treated during 2011‐2016 were registered. Pericardial effusion (n = 105), massive bleeding (n = 108), stroke (n = 6), atrial‐esophageal fistula (n = 2), and other 114 complications occurred in 323 patients (3.0%). Univariate analysis revealed that age ≧ 65 years, female gender, heart failure, CHA2DS2‐VASc≧3, hemodialysis, deep sedation, and complex fractionated atrial electrogram (CFAE)‐guided ablation ([+] vs [−] = 4.3% vs 2.8%, P = .005) were related with the higher incidence of complications. Redo session, 3‐D imaging system ([+] vs [−]: 4.4% vs 2.9%, P = .017), and periprocedural dabigatran were related with the lower incidence of complications. None of the linear ablation of the left atrium, ganglionated plexi ablation, and superior vena cava ablation affected the incidence of complications. Multiple logistic regression analysis showed that in addition to 3‐D imaging system, age ≧ 65 years, redo session, and deep sedation, CFAE ablation was an independent predictor of the risk of complications (OR 1.78, P = .001). Specifically, implantation of a permanent pacemaker due to emerging sinus node dysfunction was frequent after CFAE ablation (CFAE [+] vs [−] = 4/1047 vs 2/9748, P < .001). CONCLUSIONS: Among extra‐PV ablation strategies, CFAE‐guided ablation is a predictor of ablation‐related complications. John Wiley and Sons Inc. 2018-07-06 /pmc/articles/PMC6111468/ /pubmed/30167015 http://dx.doi.org/10.1002/joa3.12081 Text en © 2018 The Authors. Journal of Arrhythmia published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Heart Rhythm Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Murakawa, Yuji Yamane, Teiichi Goya, Masahiko Inoue, Koichi Naito, Shigeto Kumagai, Koichiro Miyauchi, Yasushi Morita, Norishige Nogami, Akihiko Shoda, Morio Okumura, Ken Hirao, Kenzo Influence of substrate modification in catheter ablation of atrial fibrillation on the incidence of acute complications: Analysis of 10 795 procedures in J‐CARAF Study 2011‐2016 |
title | Influence of substrate modification in catheter ablation of atrial fibrillation on the incidence of acute complications: Analysis of 10 795 procedures in J‐CARAF Study 2011‐2016 |
title_full | Influence of substrate modification in catheter ablation of atrial fibrillation on the incidence of acute complications: Analysis of 10 795 procedures in J‐CARAF Study 2011‐2016 |
title_fullStr | Influence of substrate modification in catheter ablation of atrial fibrillation on the incidence of acute complications: Analysis of 10 795 procedures in J‐CARAF Study 2011‐2016 |
title_full_unstemmed | Influence of substrate modification in catheter ablation of atrial fibrillation on the incidence of acute complications: Analysis of 10 795 procedures in J‐CARAF Study 2011‐2016 |
title_short | Influence of substrate modification in catheter ablation of atrial fibrillation on the incidence of acute complications: Analysis of 10 795 procedures in J‐CARAF Study 2011‐2016 |
title_sort | influence of substrate modification in catheter ablation of atrial fibrillation on the incidence of acute complications: analysis of 10 795 procedures in j‐caraf study 2011‐2016 |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111468/ https://www.ncbi.nlm.nih.gov/pubmed/30167015 http://dx.doi.org/10.1002/joa3.12081 |
work_keys_str_mv | AT murakawayuji influenceofsubstratemodificationincatheterablationofatrialfibrillationontheincidenceofacutecomplicationsanalysisof10795proceduresinjcarafstudy20112016 AT yamaneteiichi influenceofsubstratemodificationincatheterablationofatrialfibrillationontheincidenceofacutecomplicationsanalysisof10795proceduresinjcarafstudy20112016 AT goyamasahiko influenceofsubstratemodificationincatheterablationofatrialfibrillationontheincidenceofacutecomplicationsanalysisof10795proceduresinjcarafstudy20112016 AT inouekoichi influenceofsubstratemodificationincatheterablationofatrialfibrillationontheincidenceofacutecomplicationsanalysisof10795proceduresinjcarafstudy20112016 AT naitoshigeto influenceofsubstratemodificationincatheterablationofatrialfibrillationontheincidenceofacutecomplicationsanalysisof10795proceduresinjcarafstudy20112016 AT kumagaikoichiro influenceofsubstratemodificationincatheterablationofatrialfibrillationontheincidenceofacutecomplicationsanalysisof10795proceduresinjcarafstudy20112016 AT miyauchiyasushi influenceofsubstratemodificationincatheterablationofatrialfibrillationontheincidenceofacutecomplicationsanalysisof10795proceduresinjcarafstudy20112016 AT moritanorishige influenceofsubstratemodificationincatheterablationofatrialfibrillationontheincidenceofacutecomplicationsanalysisof10795proceduresinjcarafstudy20112016 AT nogamiakihiko influenceofsubstratemodificationincatheterablationofatrialfibrillationontheincidenceofacutecomplicationsanalysisof10795proceduresinjcarafstudy20112016 AT shodamorio influenceofsubstratemodificationincatheterablationofatrialfibrillationontheincidenceofacutecomplicationsanalysisof10795proceduresinjcarafstudy20112016 AT okumuraken influenceofsubstratemodificationincatheterablationofatrialfibrillationontheincidenceofacutecomplicationsanalysisof10795proceduresinjcarafstudy20112016 AT hiraokenzo influenceofsubstratemodificationincatheterablationofatrialfibrillationontheincidenceofacutecomplicationsanalysisof10795proceduresinjcarafstudy20112016 AT influenceofsubstratemodificationincatheterablationofatrialfibrillationontheincidenceofacutecomplicationsanalysisof10795proceduresinjcarafstudy20112016 |